Business News›Markets›Stocks›Stock Liveblog›Dr. Reddy's Laboratories Share Price Live Updates: Dr. Reddy's Laboratories Closes at Rs 6,999.30, Achieving 16.64% Returns Over Three Months
LIVE BLOG
Dr. Reddy's Laboratories Share Price Live Updates: Dr. Reddy's Laboratories Closes at Rs 6,999.30, Achieving 16.64% Returns Over Three Months
29 Aug 2024 | 10:08:25 AM IST
Stay informed with the Dr. Reddy's Laboratories Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a leading stock. Get the latest details on Dr. Reddy's Laboratories, including: Last traded price 6898.3, Market capitalization: 116769.11, Volume: 4070, Price-to-earnings ratio 20.98, Earnings per share 333.59. Our liveblog combines fundamental and technical insights to provide a holistic view of Dr. Reddy's Laboratories's performance. Stay ahead of the market with breaking news that can influence Dr. Reddy's Laboratories's trajectory. Our expert analysis and stock recommendations empower you to make well-informed financial decisions. Trust the Dr. Reddy's Laboratories Stock Liveblog for up-to-date information and expert insights. The data points are updated as on 29-08-2024 09:13 IST
Show more1 New Update
Dr. Reddy's Laboratories Share Price Live Updates: Dr. Reddy's Laboratories Stock Details
Discover the latest market updates and real-time stock information on Dr. Reddy's Laboratories Stock
Dr. Reddy's Laboratories Share Price Live Updates: Dr. Reddy's Laboratories Sees Minor Decline Amidst Stable Weekly Returns
Dr. Reddy's Laboratories is currently trading at Rs 6939.95, reflecting a slight decline of 0.85% in today's market session. Over the past week, the stock has demonstrated a modest return of 0.63%, indicating a stable performance amidst fluctuating market conditions. Investors may find this trend noteworthy as they assess the company's ongoing market position.
Dr. Reddy's Laboratories Share Price Live Updates: Dr. Reddy's Laboratories Closes at Rs 6,999.30, Achieving 16.64% Returns Over Three Months
Dr. Reddy's Laboratories concluded the previous trading session with a closing price of Rs 6,999.30. Over the past three months, the company's stock has demonstrated a robust performance, yielding a return of 16.64%. This positive trend reflects the market's confidence in the company's strategic initiatives and overall financial health.
Dr. Reddy's Laboratories Share Price Live Updates: Dr. Reddy's Laboratories Closes at Rs 6,999.30 with Increased Trading Volume
Dr. Reddy's Laboratories concluded the previous trading session with a closing price of Rs 6,999.30. The stock experienced a trading volume of 326,517 shares, which notably exceeded the average volume of 303,857 shares observed over the past seven days, indicating heightened investor interest and activity in the market.
Dr. Reddy's Laboratories Share Price Live Updates: Dr. Reddy's Laboratories Closes at Rs 6,999.30 with 1.75% Monthly Returns
Dr. Reddy's Laboratories concluded the previous trading session with a closing price of Rs 6,999.30. Over the past month, the company's stock has demonstrated a return of 1.75%, reflecting a modest yet positive performance in the financial markets. Investors may find this trend indicative of the company's resilience and potential for future growth.
Dr. Reddy's Laboratories Share Price Live Updates: Dr. Reddy's Laboratories Closes at Rs 6999.30 with Low Volatility Indicator
Dr. Reddy's Laboratories concluded the previous trading session with a closing price of Rs 6999.30. The company's six-month beta stands at 0.2055, indicating a relatively low level of volatility compared to the broader market. This stability may appeal to investors seeking consistent performance amidst fluctuating market conditions.
Dr. Reddy's Laboratories Share Price Live Updates: Dr. Reddy's Laboratories Closes at Rs 6999.30 with 0.52% Gain and 326,517 Shares Traded
On the previous trading day, Dr. Reddy's Laboratories concluded with a closing price of Rs 6999.30, reflecting a modest increase of 0.52% from the prior session. The trading volume for the day reached 326,517 shares, indicating a steady interest among investors in the pharmaceutical sector.
